Author

A. O'Neill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 1

Frequent Co-Authors

A. Kadioglu· 1 shared A. Lubben· 1 shared A. Pustilnik· 1 shared A. Yadav· 1 shared B. A. Heinz· 1 shared B. Pascoe· 1 shared C. A. Cohen· 1 shared C. Campbell· 1 shared

Activity by Year

2017-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Kadioglu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

K. Westendorf, S. Zentelis, L. Wang, D. Foster, P. Vaillancourt, M. Wiggin, E. Lovett, R. van der Lee, J. Hendle, A. Pustilnik, J. M. Sauder, L. Kraft, Y. Hwang, R. W. Siegel, J. Chen, , Ramamurt

This paper identifies LY-CoV1404, a potent SARS-CoV-2 neutralizing antibody effective against multiple variants, including Omicron and Delta, due to its conserved epitope and resistance to common mutations.

bioRxiv · Apr 30, 2021Immunology

Impaired alanine transport or exposure to D-cycloserine increases the susceptibility of MRSA to beta-lactam antibiotics

L. Gallagher, R. K. Shears, C. Fingleton, L. Alvarez, E. Waters, J. Clarke, L. Bricio-Moreno, C. Campbell, A. Yadav, F. Razvi, E. O'Neill, A. O'Neill, F. Cava, P. Fey, A. Kadioglu, J. P. O'Gara

The paper shows that impairing alanine transport or exposing MRSA to D-cycloserine increases susceptibility to beta-lactam antibiotics by reducing peptidoglycan crosslinking.

bioRxiv · Sep 19, 2019Microbiology

Hidden antibiotic resistance fitness costs revealed by GWAS-based epistasis analysis

M. Yokoyama, M. Laabei, E. Stevens, S. Bayliss, N. Ooi, A. O'Neill, E. Murray, P. Williams, A. Lubben, S. Reeksting, G. Meric, B. Pascoe, S. Sheppard, M. Recker, L. Hurst, R. Massey

The paper identifies hidden fitness costs of mupirocin resistance in Staphylococcus aureus using GWAS and proteomics, revealing pleiotropic effects on toxin production and virulence.

bioRxiv · Dec 9, 2017Microbiology